These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 32217761)

  • 21. Integrative 5-Methylcytosine Modification Immunologically Reprograms Tumor Microenvironment Characterizations and Phenotypes of Clear Cell Renal Cell Carcinoma.
    Xu W; Zhu W; Tian X; Liu W; Wu Y; Anwaier A; Su J; Wei S; Qu Y; Zhang H; Ye D
    Front Cell Dev Biol; 2021; 9():772436. PubMed ID: 34957104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic and Predictive Value of Tumor-infiltrating Leukocytes and of Immune Checkpoint Molecules PD1 and PDL1 in Clear Cell Renal Cell Carcinoma.
    Stenzel PJ; Schindeldecker M; Tagscherer KE; Foersch S; Herpel E; Hohenfellner M; Hatiboglu G; Alt J; Thomas C; Haferkamp A; Roth W; Macher-Goeppinger S
    Transl Oncol; 2020 Feb; 13(2):336-345. PubMed ID: 31881506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TACC3 is a prognostic biomarker for kidney renal clear cell carcinoma and correlates with immune cell infiltration and T cell exhaustion.
    Fan X; Liu B; Wang Z; He D
    Aging (Albany NY); 2021 Mar; 13(6):8541-8562. PubMed ID: 33714201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DAB2IP Plays Important Clinical Significance and Correlates With Immune Infiltration in Renal Cell Carcinoma.
    Cao H; Zhang J; Wang W
    Technol Cancer Res Treat; 2020; 19():1533033820936682. PubMed ID: 32583730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic Landscape of Chinese Clear Cell Renal Cell Carcinoma Patients With Venous Tumor Thrombus Identifies Chromosome 9 and 14 Deletions and Related Immunosuppressive Microenvironment.
    Niu S; Liu K; Xu Y; Peng C; Yu Y; Huang Q; Wu S; Cui B; Huang Y; Ma X; Zhang X; Wang B
    Front Oncol; 2021; 11():646338. PubMed ID: 34249685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune landscape of renal cell carcinoma with metastasis to the pancreas.
    Kippenberger M; Schönberg G; Kaczorowski A; Schneider F; Böning S; Sun A; Schwab C; Görtz M; Schütz V; Stenzinger A; Hohenfellner M; Duensing A; Duensing S
    Urol Oncol; 2024 Nov; 42(11):373.e9-373.e17. PubMed ID: 38981801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Baseline circulating unswitched memory B cells and B-cell related soluble factors are associated with overall survival in patients with clear cell renal cell carcinoma treated with nivolumab within the NIVOREN GETUG-AFU 26 study.
    Carril-Ajuria L; Desnoyer A; Meylan M; Dalban C; Naigeon M; Cassard L; Vano Y; Rioux-Leclercq N; Chouaib S; Beuselinck B; Chabaud S; Barros-Monteiro J; Bougoüin A; Lacroix G; Colina-Moreno I; Tantot F; Boselli L; De Oliveira C; Fridman WH; Escudier B; Sautes-Fridman C; Albiges L; Chaput-Gras N
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35640928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LAGE3 correlates with tumorigenic immune infiltrates in the clear cell renal cell carcinoma microenvironment.
    Dong X; Gu DN; Wang O; Ye Z
    Int Immunopharmacol; 2020 Oct; 87():106793. PubMed ID: 32683301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pattern and prognostic relevance of immune activity scores and tumor-infiltrating immune cells in metastatic clear cell renal cell carcinoma: Evidence from multiple datasets.
    Shi B; Qi J
    Int Immunopharmacol; 2020 Aug; 85():106651. PubMed ID: 32505901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor Infiltrating Mast Cells (TIMs) Confers a Marked Survival Advantage in Nonmetastatic Clear-Cell Renal Cell Carcinoma.
    Fu H; Zhu Y; Wang Y; Liu Z; Zhang J; Wang Z; Xie H; Dai B; Xu J; Ye D
    Ann Surg Oncol; 2017 May; 24(5):1435-1442. PubMed ID: 27896514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integration of intratumoral RASSF10 expression and tumor-associated macrophages into the established clinical indicators better predicts the prognosis of clear cell renal cell carcinoma patients.
    Wang C; Hong T; Wang Y; Gan S; Wang Q; Li J; Zuo L; Cui X
    Oncoimmunology; 2020; 9(1):1736793. PubMed ID: 32313718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor-infiltrating TNFRSF9
    Li Y; Wang Z; Jiang W; Zeng H; Liu Z; Lin Z; Qu Y; Xiong Y; Wang J; Chang Y; Bai Q; Wang Y; Liu L; Zhu Y; Xu L; Xia Y; Guo J; Xu J
    Oncoimmunology; 2020 Oct; 9(1):1838141. PubMed ID: 33178496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive analyses of immune tumor microenvironment in papillary renal cell carcinoma.
    de Vries-Brilland M; Rioux-Leclercq N; Meylan M; Dauvé J; Passot C; Spirina-Menand E; Flippot R; Fromont G; Gravis G; Geoffrois L; Chevreau C; Rolland F; Blanc E; Lefort F; Ravaud A; Gross-Goupil M; Escudier B; Negrier S; Albiges L
    J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 37935564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The unique genomic landscape and prognostic mutational signature of Chinese clear cell renal cell carcinoma.
    Xu W; Anwaier A; Liu W; Tian X; Su J; Shi G; Qu Y; Zhang H; Ye D
    J Natl Cancer Cent; 2022 Sep; 2(3):162-170. PubMed ID: 39036450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD8
    Wu X; Jiang D; Liu H; Lu X; Lv D; Liang L
    Front Immunol; 2021; 12():745945. PubMed ID: 34970257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intratumoral fibrosis and patterns of immune infiltration in clear cell renal cell carcinoma.
    Han S; Yang W; Qin C; Du Y; Ding M; Yin H; Xu T
    BMC Cancer; 2022 Jun; 22(1):661. PubMed ID: 35710350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CCL5-dependent mast cell infiltration into the tumor microenvironment in clear cell renal cell carcinoma patients.
    Liu T; Xia Q; Zhang H; Wang Z; Yang W; Gu X; Hou T; Chen Y; Pei X; Zhu G; He D; Li L; Xu S
    Aging (Albany NY); 2020 Nov; 12(21):21809-21836. PubMed ID: 33177244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of multiple tumor-infiltrating immune cells predicts clinical outcome in colon cancer.
    Zhang X; Quan F; Xu J; Xiao Y; Li X; Li Y
    Clin Immunol; 2020 Jun; 215():108412. PubMed ID: 32278085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy.
    Reustle A; Di Marco M; Meyerhoff C; Nelde A; Walz JS; Winter S; Kandabarau S; Büttner F; Haag M; Backert L; Kowalewski DJ; Rausch S; Hennenlotter J; Stühler V; Scharpf M; Fend F; Stenzl A; Rammensee HG; Bedke J; Stevanović S; Schwab M; Schaeffeler E
    Genome Med; 2020 Mar; 12(1):32. PubMed ID: 32228647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.